ATLASHealthcare earnings calendar: upcoming and recent reports
793 Healthcare companies report earnings over the next 45 days, led by Amgen (AMGN), Novo Nordisk A/S (NVO) and Pfizer (PFE). 177 reported over the last 45 days; 80% of those with an EPS estimate came in above it and the average move around the report was 4.0%.
Source: company filings and exchange data · Updated Nov 2, 2026
Get this week’s earnings in your inbox every Monday
ATLAS Signals lists the biggest reports of the week, with ATLAS’s read on each, plus three stocks on our radar. One email, one-click unsubscribe.
ATLAS Signals
ATLAS Signals, every week
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy
Healthcare: upcoming earnings (next 45 days)
| Company | Date | Time | EPS est. | ATLAS chance up (1 mo) | Likely range (50%) | Fair value vs price |
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals VRTX · ATLAS page | Mon, Nov 2 | After close | $4.36 | 51% | $532.24 – $589.41 | $342.16 ($235.66–$414.19) · 63% above |
| IDEXX Laboratories IDXX · ATLAS page | Mon, Nov 2 | Before open | $3.71 | 51% | $523.23 – $582.73 | $329.05 ($240.73–$449.79) · 68% above |
| Neurocrine Biosciences NBIX · ATLAS page | Mon, Nov 2 | After close | $1.99 | 52% | $139.65 – $153.66 | $279.82 ($171.40–$456.82) · 48% below |
| Jazz Pharmaceuticals JAZZ · ATLAS page | Mon, Nov 2 | After close | -$5.18 | 51% | $205.10 – $228.26 | $488.98 ($354.62–$736.25) · 56% below |
| Tempus AI TEM · ATLAS page | Mon, Nov 2 | Before open | -$0.32 | 45% | $60.52 – $81.81 | – |
| Summit Therapeutics SMMT · ATLAS page | Mon, Nov 2 | – | -$0.28 | 47% | $13.94 – $17.86 | – |
| BioMarin Pharmaceutical BMRN · ATLAS page | Mon, Nov 2 | After close | -$0.30 | 51% | $55.75 – $61.68 | – |
| Krystal Biotech KRYS · ATLAS page | Mon, Nov 2 | Before open | $1.84 | 50% | $311.77 – $354.23 | $297.56 ($207.55–$426.60) · 12% above |
| TG Therapeutics TGTX · ATLAS page | Mon, Nov 2 | Before open | $0.37 | 49% | $55.91 – $66.35 | $38.44 ($14.91–$98.11) · 59% above |
| Hinge Health HNGE · ATLAS page | Mon, Nov 2 | After close | $0.27 | 50% | $106.81 – $122.22 | $57.96 ($55.36–$91.99) · 97% above |
| Axsome Therapeutics AXSM · ATLAS page | Mon, Nov 2 | Before open | -$0.68 | 49% | $133.27 – $155.70 | – |
| Amgen AMGN · ATLAS page | Tue, Nov 3 | After close | $5.74 | 51% | $444.95 – $490.51 | $459.42 ($272.07–$594.37) · 1% above |
| Pfizer PFE · ATLAS page | Tue, Nov 3 | Before open | $0.72 | 53% | $29.51 – $31.81 | $36.78 ($28.69–$67.48) · 17% below |
| Teva Pharmaceutical Industries TEVA · ATLAS page | Tue, Nov 3 | Before open | $0.70 | 51% | $39.91 – $44.53 | $19.61 ($13.66–$33.47) · 115% above |
| Waters WAT · ATLAS page | Tue, Nov 3 | Before open | $3.99 | 51% | $440.30 – $488.31 | – |
| Koninklijke Philips N.V. ADR PHG · ATLAS page | Tue, Nov 3 | Before open | $0.37 | 52% | $25.83 – $28.23 | $26.19 ($18.98–$36.15) · 3% above |
| Revvity RVTY · ATLAS page | Tue, Nov 3 | Before open | $1.29 | 50% | $147.57 – $167.16 | $76.74 ($45.67–$91.41) · 105% above |
| Madrigal Pharmaceuticals MDGL · ATLAS page | Tue, Nov 3 | Before open | -$1.09 | 50% | $402.13 – $460.08 | – |
| Vaxcyte PCVX · ATLAS page | Tue, Nov 3 | After close | -$1.84 | 47% | $54.12 – $69.01 | – |
| Henry Schein HSIC · ATLAS page | Tue, Nov 3 | Before open | $1.34 | 53% | $82.17 – $88.38 | $103.94 ($80.39–$134.38) · 18% below |
| Spyre Therapeutics SYRE · ATLAS page | Tue, Nov 3 | After close | -$0.79 | 47% | $84.90 – $107.01 | – |
| ImmunityBio IBRX · ATLAS page | Tue, Nov 3 | Before open | -$0.08 | 46% | $7.05 – $9.33 | – |
| Corcept Therapeutics CORT · ATLAS page | Tue, Nov 3 | After close | $0.68 | 46% | $69.02 – $91.30 | $42.79 ($32.86–$57.60) · 90% above |
| Alkermes ALKS · ATLAS page | Tue, Nov 3 | Before open | -$0.08 | 51% | $42.88 – $48.06 | $45.94 ($31.62–$69.20) · 1% below |
| Amneal Pharmaceuticals AMRX · ATLAS page | Tue, Nov 3 | Before open | $0.23 | 50% | $20.15 – $22.96 | $20.35 ($15.58–$33.84) · 6% above |
| PACS Group PACS · ATLAS page | Tue, Nov 3 | After close | $0.56 | 49% | $44.43 – $51.30 | $30.51 ($25.91–$35.58) · 57% above |
| Rhythm Pharmaceuticals RYTM · ATLAS page | Tue, Nov 3 | Before open | -$0.68 | 49% | $85.94 – $99.39 | – |
| Novo Nordisk A/S NVO · ATLAS page | Wed, Nov 4 | Before open | $0.81 | 51% | $37.97 – $42.29 | $32.69 ($24.29–$46.13) · 22% above |
| McKesson MCK · ATLAS page | Wed, Nov 4 | After close | $10.69 | 52% | $954.92 – $1,042.40 | $1,292.34 ($931.46–$1,824.03) · 23% below |
| CVS Health CVS · ATLAS page | Wed, Nov 4 | Before open | $1.62 | 52% | $86.66 – $94.58 | $88.84 ($79.96–$97.73) · 2% above |
| Cencora COR · ATLAS page | Wed, Nov 4 | Before open | $4.55 | 53% | $320.06 – $344.67 | $554.61 ($469.29–$934.21) · 40% below |
| Edwards Lifesciences EW · ATLAS page | Wed, Nov 4 | After close | $0.73 | 52% | $88.16 – $96.59 | $55.50 ($51.93–$86.89) · 66% above |
| Medline MDLN · ATLAS page | Wed, Nov 4 | Before open | $0.32 | 49% | $29.69 – $34.59 | $32.74 ($21.37–$46.89) · 2% below |
| Revolution Medicines RVMD · ATLAS page | Wed, Nov 4 | After close | -$2.34 | 49% | $175.87 – $206.72 | – |
| Royalty Pharma RPRX · ATLAS page | Wed, Nov 4 | Before open | $1.18 | 52% | $64.50 – $70.41 | $43.88 ($34.78–$54.80) · 53% above |
| United Therapeutics UTHR · ATLAS page | Wed, Nov 4 | Before open | $5.85 | 50% | $563.60 – $636.79 | $926.46 ($791.98–$1,433.91) · 35% below |
| STERIS STE · ATLAS page | Wed, Nov 4 | After close | $2.67 | 52% | $218.06 – $238.04 | $228.67 ($157.82–$294.10) · 1% below |
| Zimmer Biomet ZBH · ATLAS page | Wed, Nov 4 | Before open | $1.89 | 51% | $90.16 – $99.56 | $168.67 ($137.63–$206.71) · 44% below |
| Charles River Laboratories International CRL · ATLAS page | Wed, Nov 4 | Before open | $2.98 | 49% | $329.87 – $388.76 | – |
| Bio-Techne TECH · ATLAS page | Wed, Nov 4 | – | $0.40 | 53% | $70.47 – $75.54 | $29.61 ($21.37–$41.03) · 145% above |
| Insulet PODD · ATLAS page | Wed, Nov 4 | Before open | $1.59 | 50% | $140.85 – $159.24 | $158.21 ($130.45–$232.40) · 5% below |
| Qiagen N.V. QGEN · ATLAS page | Wed, Nov 4 | After close | $0.63 | 51% | $47.93 – $52.88 | $51.30 ($40.82–$64.46) · 2% below |
| Bio-Rad Laboratories BIO · ATLAS page | Wed, Nov 4 | After close | $2.61 | 51% | $353.07 – $393.65 | $246.90 ($180.99–$294.88) · 51% above |
| Caris Life Sciences CAI · ATLAS page | Wed, Nov 4 | After close | $0.03 | 48% | $30.69 – $37.71 | $14.80 ($11.58–$18.92) · 132% above |
| Cytokinetics CYTK · ATLAS page | Wed, Nov 4 | After close | -$1.50 | 50% | $59.11 – $67.15 | – |
| Bruker BRKR · ATLAS page | Wed, Nov 4 | Before open | $0.42 | 48% | $51.67 – $62.24 | – |
| Ionis Pharmaceuticals IONS · ATLAS page | Wed, Nov 4 | Before open | -$1.22 | 50% | $40.59 – $46.59 | – |
| GRAIL GRAL · ATLAS page | Wed, Nov 4 | After close | -$2.78 | 44% | $116.51 – $164.38 | – |
| Cigna Group CI · ATLAS page | Thu, Nov 5 | Before open | $7.46 | 52% | $285.05 – $313.66 | $572.28 ($515.05–$629.51) · 48% below |
| Natera NTRA · ATLAS page | Thu, Nov 5 | After close | -$0.17 | 49% | $381.89 – $446.91 | $139.02 ($125.12–$152.93) · 198% above |
+743 more Healthcare reports in this window; the table lists the largest by market value.
ATLAS columns: chance of a higher price in 1 month, the likely 1-month price range and the fair value with its range, from each company’s ATLAS page. They describe an ordinary period, not the earnings reaction.
Healthcare: recent earnings results (last 45 days)
| Company | Date | Time | EPS est. | EPS reported | Surprise | Move* | ATLAS chance up (1 mo) | Likely range (50%) | Fair value vs price |
|---|---|---|---|---|---|---|---|---|---|
| AbbVie ABBV · ATLAS page | Fri, Oct 30 | – | $3.74 | $3.82 | +2.1% | – | 53% | $285.46 – $307.06 | $156.39 ($122.65–$199.42) · 89% above |
| AstraZeneca AZN · ATLAS page | Fri, Oct 30 | – | $2.60 | $2.79 | +7.3% | – | 50% | $176.03 – $198.25 | $232.68 ($168.27–$339.55) · 20% below |
| Regeneron Pharmaceuticals REGN · ATLAS page | Fri, Oct 30 | – | $13.76 | $18.43 | +33.9% | – | 49% | $847.31 – $1,006.80 | $986.58 ($762.47–$1,276.58) · 6% below |
| BrightSpring Health Services BTSG · ATLAS page | Fri, Oct 30 | – | $0.45 | $0.54 | +20.0% | – | 49% | $61.10 – $72.56 | $54.26 ($33.99–$60.40) · 23% above |
| Regencell Bioscience RGC · ATLAS page | Fri, Oct 30 | – | – | – | – | – | 42% | $5.07 – $7.85 | – |
| Eli Lilly LLY · ATLAS page | Thu, Oct 29 | – | $5.38 | $7.48 | +39.0% | – | 50% | $1,330.79 – $1,510.54 | $677.93 ($511.11–$899.20) · 109% above |
| Merck & Co. MRK · ATLAS page | Thu, Oct 29 | – | $2.12 | $2.49 | +17.5% | – | 51% | $142.02 – $158.00 | $88.37 ($62.03–$125.88) · 69% above |
| Gilead Sciences GILD · ATLAS page | Thu, Oct 29 | – | $2.17 | $2.55 | +17.5% | – | 51% | $162.62 – $179.94 | $177.75 ($140.51–$224.86) · 4% below |
| Bristol-Myers Squibb BMY · ATLAS page | Thu, Oct 29 | – | $1.21 | $1.35 | +11.6% | – | 51% | $59.49 – $65.91 | $119.46 ($96.48–$147.92) · 48% below |
| Stryker SYK · ATLAS page | Thu, Oct 29 | – | $3.56 | $3.52 | -1.1% | – | 50% | $274.27 – $310.79 | $279.79 ($232.56–$454.01) · 4% above |
| Illumina ILMN · ATLAS page | Thu, Oct 29 | – | $1.36 | $1.44 | – | – | 45% | $199.19 – $266.52 | $127.19 ($83.08–$194.70) · 86% above |
| ResMed RMD · ATLAS page | Thu, Oct 29 | – | $2.67 | $2.91 | – | – | 50% | $214.26 – $246.28 | $290.75 ($205.01–$364.61) · 21% below |
| Alnylam Pharmaceuticals ALNY · ATLAS page | Thu, Oct 29 | – | $1.46 | $15.72 | +976.7% | – | 44% | $132.63 – $189.78 | $227.28 ($157.55–$327.88) · 27% below |
| DexCom DXCM · ATLAS page | Thu, Oct 29 | – | $0.66 | $0.73 | +10.6% | – | 50% | $77.16 – $87.76 | $67.15 ($56.74–$94.11) · 23% above |
| West Pharmaceutical Services WST · ATLAS page | Thu, Oct 29 | – | $2.18 | $2.66 | +22.0% | – | 52% | $395.36 – $433.15 | $267.17 ($206.00–$343.04) · 54% above |
| Incyte INCY · ATLAS page | Thu, Oct 29 | – | -$4.27 | -$3.79 | +11.2% | – | 51% | $114.47 – $127.11 | $84.83 ($60.13–$119.69) · 42% above |
| Tenet Healthcare THC · ATLAS page | Thu, Oct 29 | – | $4.60 | $6.64 | +44.4% | – | 51% | $259.40 – $288.86 | $581.94 ($402.14–$842.15) · 53% below |
| Insmed INSM · ATLAS page | Thu, Oct 29 | – | -$0.34 | -$0.46 | -35.3% | – | 47% | $100.43 – $123.81 | – |
| Exelixis EXEL · ATLAS page | Thu, Oct 29 | – | $0.79 | $0.85 | +7.6% | – | 51% | $65.93 – $73.31 | $124.92 ($96.79–$161.22) · 44% below |
| BridgeBio Pharma BBIO · ATLAS page | Thu, Oct 29 | – | -$0.60 | -$0.42 | +30.0% | – | 49% | $69.08 – $80.86 | – |
| Baxter International BAX · ATLAS page | Thu, Oct 29 | – | $0.51 | $0.58 | +13.7% | – | 50% | $21.45 – $24.62 | $45.31 ($29.19–$73.72) · 49% below |
| Penumbra PEN · ATLAS page | Thu, Oct 29 | – | $1.21 | $1.07 | -11.6% | – | 53% | $308.48 – $332.35 | $148.74 ($105.71–$209.28) · 114% above |
| DaVita DVA · ATLAS page | Thu, Oct 29 | – | $3.78 | $3.82 | +1.1% | – | 50% | $174.40 – $201.07 | $429.53 ($328.10–$819.62) · 56% below |
| Kymera Therapeutics KYMR · ATLAS page | Thu, Oct 29 | – | -$1.26 | -$1.32 | -4.8% | – | 49% | $115.93 – $137.18 | – |
| AptarGroup ATR · ATLAS page | Thu, Oct 29 | – | $1.46 | $1.52 | +4.1% | – | 52% | $131.57 – $143.93 | $135.07 ($106.19–$171.79) · 2% above |
| Ligand Pharmaceuticals LGND · ATLAS page | Thu, Oct 29 | – | $1.42 | -$1.43 | -200.7% | – | 51% | $304.89 – $342.41 | – |
| Merit Medical Systems MMSI · ATLAS page | Thu, Oct 29 | – | $0.93 | $1.01 | +8.6% | – | 50% | $81.04 – $91.84 | $98.31 ($73.63–$143.26) · 12% below |
| PTC Therapeutics PTCT · ATLAS page | Thu, Oct 29 | – | $0.17 | $0.61 | +258.8% | – | 49% | $55.09 – $64.83 | $50.01 ($36.55–$68.43) · 20% above |
| Travere Therapeutics TVTX · ATLAS page | Thu, Oct 29 | – | -$0.25 | – | – | – | 49% | $46.61 – $54.24 | $62.73 ($56.46–$69.01) · 20% below |
| Option Care Health OPCH · ATLAS page | Thu, Oct 29 | – | $0.44 | – | – | – | 48% | $28.51 – $34.93 | $29.91 ($22.04–$40.59) · 6% above |
| Integer ITGR · ATLAS page | Thu, Oct 29 | – | $1.65 | $1.34 | -18.8% | – | 54% | $123.16 – $131.27 | $82.49 ($44.02–$116.36) · 53% above |
| Indivior Pharmaceuticals INDV · ATLAS page | Thu, Oct 29 | – | $0.93 | $1.32 | +41.9% | – | 50% | $33.34 – $37.58 | $83.37 ($73.56–$93.54) · 58% below |
| CareDx CDNA · ATLAS page | Thu, Oct 29 | – | $0.07 | $0.52 | +642.9% | – | 45% | $73.26 – $99.01 | $68.56 ($50.99–$91.25) · 28% above |
| Fortrea FTRE · ATLAS page | Thu, Oct 29 | – | $0.24 | $0.28 | +16.7% | – | 47% | $18.59 – $23.68 | $23.44 ($16.81–$33.50) · 9% below |
| Pediatrix Medical Group MD · ATLAS page | Thu, Oct 29 | – | $0.59 | $0.67 | +13.6% | – | 51% | $28.26 – $31.56 | $40.43 ($30.09–$54.32) · 26% below |
| Boston Scientific BSX · ATLAS page | Wed, Oct 28 | – | $0.73 | $0.73 | 0.0% | – | 51% | $39.71 – $44.49 | $79.64 ($63.29–$100.23) · 47% below |
| Biogen BIIB · ATLAS page | Wed, Oct 28 | – | $2.06 | $2.62 | +27.2% | – | 51% | $240.41 – $268.40 | $183.87 ($120.78–$279.91) · 38% above |
| GE HealthCare Technologies GEHC · ATLAS page | Wed, Oct 28 | – | $1.21 | $1.34 | +10.7% | – | 51% | $72.37 – $81.20 | $95.22 ($76.91–$117.89) · 20% below |
| Labcorp LH · ATLAS page | Wed, Oct 28 | – | $4.65 | $4.78 | +2.8% | – | 50% | $340.83 – $383.86 | $321.23 ($228.58–$451.44) · 13% above |
| Encompass Health EHC · ATLAS page | Wed, Oct 28 | – | $1.37 | $1.52 | +11.0% | – | 50% | $127.25 – $145.08 | $129.43 ($80.02–$168.50) · 5% above |
137 more reported in this window.
ATLAS columns: chance of a higher price in 1 month, the likely 1-month price range and the fair value with its range, from each company’s ATLAS page. They describe an ordinary period, not the earnings reaction.
*Move: change in the closing price from the last close before the report day to the close the day after it.
Largest Healthcare companies and their next report
- Eli Lilly (LLY)
- Johnson & Johnson (JNJ)
- AbbVie (ABBV)
- UnitedHealth Group (UNH)
- Merck & Co. (MRK)
- Novartis AG (NVS)
- AstraZeneca (AZN)
- Thermo Fisher Scientific (TMO)
- Amgen (AMGN) · Nov 3
- Gilead Sciences (GILD)
- Abbott Laboratories (ABT)
- Novo Nordisk A/S (NVO) · Nov 4
- Pfizer (PFE) · Nov 3
- Danaher (DHR)
- Intuitive Surgical (ISRG)
- Vertex Pharmaceuticals (VRTX) · Nov 2
- Bristol-Myers Squibb (BMY)
- Medtronic (MDT) · Nov 17
- Stryker (SYK)
- McKesson (MCK) · Nov 4
- CVS Health (CVS) · Nov 4
- HCA Healthcare (HCA)
- Elevance Health (ELV)
- Moderna (MRNA) · Nov 6
- Regeneron Pharmaceuticals (REGN)
- Cigna Group (CI) · Nov 5
- Boston Scientific (BSX)
- Cencora (COR) · Nov 4
- Natera (NTRA) · Nov 5
- Cardinal Health (CAH) · Nov 5
- Becton, Dickinson (BDX) · Nov 5
- Edwards Lifesciences (EW) · Nov 4
- Veeva Systems (VEEV) · Nov 19
- Humana (HUM) · Nov 6
- AgileThought (A) · Nov 23
- Teva Pharmaceutical Industries (TEVA) · Nov 3
Earnings calendar: frequently asked questions
Which Healthcare companies report earnings soon?
Amgen (AMGN), Novo Nordisk A/S (NVO), Pfizer (PFE), Vertex Pharmaceuticals (VRTX), Medtronic (MDT) and McKesson (MCK) are among the largest Healthcare reports scheduled in the next 45 days. 793 are listed with a confirmed date.
How many Healthcare companies beat EPS estimates?
Of the 75 Healthcare companies that reported over the last 45 days with an EPS estimate on record, 60 (80%) reported EPS above the estimate. That is a snapshot of one window, not a forecast.
Where do these Healthcare dates come from?
Dates are confirmed report dates from company and exchange data, refreshed daily. Estimated dates are never shown here; only individual company pages show an ATLAS estimate, clearly labelled.
What is the difference between before the open and after the close?
Reports released before the open (BMO) move the stock in that same session. Reports released after the close (AMC) are first reflected the next trading day. ATLAS shows the time when the exchange data provides it.
Other sectors
Open any company page to set an email alert for its next report. Looking for a single stock? Try Apple (AAPL).
Educational information, not investment advice. Disclaimer